A prescription injectable medication used to improve blood sugar (glucose) control in adults with type 2 diabetes. It works to lower blood glucose levels. It provides long-acting basal insulin and enhances insulin secretion, and slows gastric emptying.
Indications:
- Improves glycemic control in adults with type 2 diabetes when combined with diet and exercise.
- Suitable for patients not adequately controlled with basal insulin or GLP-1 receptor agonists alone.
Main Active Ingredients:
- Insulin Glargine 100 U/mL.
- Lixisenatide 33 mcg/mL.
Precautions:
- Monitor blood glucose levels regularly to avoid hypoglycemia.
- Do not use in patients with diabetic ketoacidosis.
- Inform your doctor if pregnant, breastfeeding, or having pancreas, heart, or gastrointestinal issues.
- Avoid use with other GLP-1 receptor agonists.
- Rotate injection sites to reduce lipodystrophy and localized skin reactions.
Side Effects:
- Hypoglycemia (low blood sugar).
- Nausea, vomiting, diarrhea.
- Upper respiratory tract infection, headache.
- Severe allergic reactions (rare).
- Pancreatitis (rare).
- Heart failure risk if combined with TZDs.
Drug-Drug Interactions:
- May interact with other antidiabetic medications (insulin, sulfonylureas).
- Oral contraceptives may have reduced efficacy if taken close to injection.
- Antibiotics or acetaminophen should be taken at least 1 hour before injection.
- Inform your healthcare provider about all prescription, OTC, and herbal medications.
- Inject subcutaneously once daily within 1 hour before the first meal.
- Do not exceed 60 units per day.
- Use only clear, colorless solution; do not shake vigorously.
- Change injection sites daily to avoid skin lumps or irritation.
- The dosage as directed by a healthcare professional.
Insulin Glargine 100 Units/Ml, Lixisenatide 33 Mcg/Ml, With Zinc Chloride, Metacresol, Glycerin, Water For Injection, And Methionine.
Insulin Glargine
